Neos Therapeutics Announces Proposed Offering of Common Stock
June 26, 2017 16:01 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, June 26, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
P2D Bioscience Lead ADHD Drug Demonstrates Efficacy in Preclinical Testing
April 12, 2011 08:00 ET
|
P2D Bioscience
CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Apr 12, 2011) - P2D Bioscience (P2D, Inc.), a pharmaceutical development company, today announced that its lead Attention Deficit/Hyperactivity Disorder...